J. Castelli
Papers
2
Total Citations
26
H-Index
2
About
J. Castelli is a distinguished researcher in the field of radiation oncology, with a specialized focus on stereotactic radiosurgery and the clinical application of CyberKnife technology. Their work has significantly advanced the understanding of treatment toxicity and dose distribution, particularly in lung and brain cancer therapies. Castelli’s early seminal paper, "Analyse de la toxicité précoce des traitements par Cyberknife® des cancers pulmonaires et résultats préliminaires" (2008), with 17 citations, provided critical insights into the early toxicity profiles of CyberKnife treatments for lung cancers, establishing foundational safety parameters for this non-invasive approach. Later, their study "CyberKnife® M6™: Peripheral dose evaluation for brain treatments" (2017), cited 9 times, contributed to optimizing dose delivery precision in brain stereotactic radiosurgery, minimizing peripheral radiation exposure. These contributions have helped shape clinical protocols, improving patient outcomes by balancing efficacy with reduced side effects. Castelli’s work remains a key reference for researchers and clinicians seeking to refine stereotactic techniques, demonstrating a lasting impact on the safe and effective use of robotic radiosurgery in oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2CyberKnife® M6™: Peripheral dose evaluation for brain treatments9 citations · 2017